share_log

未名医药(002581.SZ):向100名激励对象授予1963.46万份股票期权

Shandong Sinobioway Biomedicine (002581.SZ): Granted 19.6346 million stock Options to 100 incentive targets.

Gelonghui Finance ·  Dec 23 18:02

Gelonghui reported on December 23rd that Shandong Sinobioway Biomedicine (002581.SZ) announced that the granting conditions specified in the "2024 Stock Options Incentive Plan (Draft) of Shandong Sinobioway Biomedicine Co., Ltd." have been achieved. According to the authorization of the fourth interim Shareholders' Meeting of Shandong Sinobioway Biomedicine Co., Ltd. in 2024, the company held the 31st meeting of the fifth Board of Directors and the 21st meeting of the fifth Supervisory Board on December 20, 2024, to review and approve the proposal on granting stock options to the incentive objects of the company's 2024 Stock Options Incentive Plan. It was agreed that December 20, 2024, would be the stock options granting date, and stock options would be granted at an exercise price of 12.35 yuan/share to 100 eligible incentive objects, totaling 19.6346 million stock options.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment